Literature DB >> 6432091

Metabolic acidosis induced by carbonic anhydrase inhibitors and salicylates in patients with normal renal function.

R A Cowan, G G Hartnell, C P Lowdell, I M Baird, A M Leak.   

Abstract

Two young patients with unimpaired renal and hepatic function were found to have developed metabolic acidosis after treatment for glaucoma and joint pain with a combination of salicylates and carbonic anhydrase inhibitors in normal doses. Carbonic anhydrase inhibitors appear to interact with salicylates to produce serious metabolic acidosis in patients without the predisposing factors generally considered to constitute risks. It is recommended that treatment combining salicylates and carbonic anhydrase inhibitors is either kept to a minimum or avoided.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6432091      PMCID： PMC1442363          DOI： 10.1136/bmj.289.6441.347

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


  6 in total

1.  Carbonic anhydrase inhibition. III. Effects of diamox on electrolyte metabolism.

Authors:  T H MAREN; B C WADSWORTH; E K YALE; L G ALONSO
Journal:  Bull Johns Hopkins Hosp       Date:  1954-12

2.  Metabolic acidosis secondary to acetazolamide therapy a possible hazardous side effect after prolonged use of acetazolamide in geriatric patients. A case report.

Authors:  G Lastnick
Journal:  Ariz Med       Date:  1975-01

3.  Acetazolamide and symptomatic metabolic acidosis in mild renal failure.

Authors:  D N Maisey; R D Brown
Journal:  Br Med J (Clin Res Ed)       Date:  1981-12-05

4.  A case of acetazolamide induced (Diamox) acidotic coma in polycystic renal disease.

Authors:  P J O'Sullivan; J G Crowley; F P Muldowney
Journal:  J Ir Med Assoc       Date:  1967-10

5.  The renal response to administration of acetazolamide (diamox) during salicylate intoxication.

Authors:  R SCHWARTZ; F X FELLERS; J KNAPP; S YAFFE
Journal:  Pediatrics       Date:  1959-06       Impact factor: 7.124

6.  Severe acidosis from acetazolamide in a diabetic patient.

Authors:  P Siklos; R G Henderson
Journal:  Curr Med Res Opin       Date:  1979       Impact factor: 2.580
  6 in total
  7 in total

1.  Acetazolamide-induced adynamic ileus.

Authors:  Massimo Gallerani; Maura Coletti; Mauro Ferri; Nicoletta Napolitano; Benedetta Boari
Journal:  Intern Emerg Med       Date:  2009-12       Impact factor: 3.397

2.  Matching the Drug to the Patient: The rational use of antiarthritic drugs.

Authors:  P Lee
Journal:  Can Fam Physician       Date:  1991-01       Impact factor: 3.275

Review 3.  Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.

Authors:  J O Miners
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

Review 4.  Salicylate intoxication in the elderly. Recognition and recommendations on how to prevent it.

Authors:  C Durnas; B J Cusack
Journal:  Drugs Aging       Date:  1992 Jan-Feb       Impact factor: 3.923

5.  Conventional and emerging treatments in the management of acute primary angle closure.

Authors:  Pui Yi Boey; Shweta Singhal; Shamira A Perera; Tin Aung
Journal:  Clin Ophthalmol       Date:  2012-03-15

6.  Argon laser peripheral iridoplasty versus systemic intraocular pressure-lowering medications as immediate management for acute phacomorphic angle closure.

Authors:  Jacky Wy Lee; Jimmy Sm Lai; Doris Wf Yick; Can Yf Yuen
Journal:  Clin Ophthalmol       Date:  2013-01-09

7.  Open-Label, Dose-Escalation, Phase 1 Study of Safety and Single and Multiple-Dose Pharmacokinetics of Dichlorphenamide in Healthy Volunteers.

Authors:  Fredric Cohen
Journal:  Clin Pharmacol Drug Dev       Date:  2018-05-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.